320 related articles for article (PubMed ID: 19298498)
1. Temporal discrepancies in the association between the apoB/apoA-I ratio and mortality in incident dialysis patients.
Chmielewski M; Carrero JJ; Qureshi AR; Axelsson J; Heimbürger O; Berglund L; Bárány P; Rutkowski B; Lindholm B; Stenvinkel P
J Intern Med; 2009 Jun; 265(6):708-16. PubMed ID: 19298498
[TBL] [Abstract][Full Text] [Related]
2. Stroke mortality and the apoB/apoA-I ratio: results of the AMORIS prospective study.
Walldius G; Aastveit AH; Jungner I
J Intern Med; 2006 Mar; 259(3):259-66. PubMed ID: 16476103
[TBL] [Abstract][Full Text] [Related]
3. Is there any survival advantage of obesity in Southern European haemodialysis patients?
Chazot C; Gassia JP; Di Benedetto A; Cesare S; Ponce P; Marcelli D
Nephrol Dial Transplant; 2009 Sep; 24(9):2871-6. PubMed ID: 19369686
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of apolipoprotein B and A-I in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA/KORA Augsburg cohort study.
Meisinger C; Loewel H; Mraz W; Koenig W
Eur Heart J; 2005 Feb; 26(3):271-8. PubMed ID: 15618061
[TBL] [Abstract][Full Text] [Related]
5. Association between a self-rated health question and mortality in young and old dialysis patients: a cohort study.
Thong MS; Kaptein AA; Benyamini Y; Krediet RT; Boeschoten EW; Dekker FW;
Am J Kidney Dis; 2008 Jul; 52(1):111-7. PubMed ID: 18511166
[TBL] [Abstract][Full Text] [Related]
6. The association of lipid-modifying medications with mortality in patients on long-term peritoneal dialysis.
Goldfarb-Rumyantzev AS; Habib AN; Baird BC; Barenbaum LL; Cheung AK
Am J Kidney Dis; 2007 Nov; 50(5):791-802. PubMed ID: 17954292
[TBL] [Abstract][Full Text] [Related]
7. ApoB/ApoA-I ratio in young patients with ischemic cerebral stroke or peripheral arterial disease.
Sabino AP; De Oliveira Sousa M; Moreira Lima L; Dias Ribeiro D; Sant'Ana Dusse LM; Das Graças Carvalho M; Fernandes AP
Transl Res; 2008 Sep; 152(3):113-8. PubMed ID: 18774540
[TBL] [Abstract][Full Text] [Related]
8. Impact of the apolipoprotein B/apolipoprotein A-I ratio on renal outcome in immunoglobulin A nephropathy.
Lundberg S; Gunnarsson I; Jacobson SH
Scand J Urol Nephrol; 2012 Apr; 46(2):148-55. PubMed ID: 22214235
[TBL] [Abstract][Full Text] [Related]
9. ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects.
Sierra-Johnson J; Romero-Corral A; Somers VK; Lopez-Jimenez F; Walldius G; Hamsten A; Hellénius ML; Fisher RM
Eur Heart J; 2007 Nov; 28(21):2637-43. PubMed ID: 17766927
[TBL] [Abstract][Full Text] [Related]
10. Errors that result from using the TC/HDL C ratio rather than the apoB/apoA-I ratio to identify the lipoprotein-related risk of vascular disease.
Sniderman AD; Jungner I; Holme I; Aastveit A; Walldius G
J Intern Med; 2006 May; 259(5):455-61. PubMed ID: 16629851
[TBL] [Abstract][Full Text] [Related]
11. Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition.
de Mutsert R; Grootendorst DC; Indemans F; Boeschoten EW; Krediet RT; Dekker FW;
J Ren Nutr; 2009 Mar; 19(2):127-35. PubMed ID: 19218039
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein A-IV concentrations and clinical outcomes in haemodialysis patients with type 2 diabetes mellitus--a post hoc analysis of the 4D Study.
Kollerits B; Krane V; Drechsler C; Lamina C; März W; Ritz E; Wanner C; Kronenberg F;
J Intern Med; 2012 Dec; 272(6):592-600. PubMed ID: 22891946
[TBL] [Abstract][Full Text] [Related]
13. The apolipoprotein B/AI ratio and the metabolic syndrome independently predict risk for myocardial infarction in middle-aged men.
Lind L; Vessby B; Sundström J
Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):406-10. PubMed ID: 16306426
[TBL] [Abstract][Full Text] [Related]
14. Increased apoB/apoA-I ratio is predictive of peripheral arterial disease in initially healthy 58-year-old men during 8.9 years of follow-up.
Johansson L; Schmidt C
Angiology; 2009; 60(5):539-45. PubMed ID: 19022789
[TBL] [Abstract][Full Text] [Related]
15. The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence.
Walldius G; Jungner I
J Intern Med; 2006 May; 259(5):493-519. PubMed ID: 16629855
[TBL] [Abstract][Full Text] [Related]
16. Association of body mass index with decline in residual kidney function after initiation of dialysis.
Drechsler C; de Mutsert R; Grootendorst DC; Boeschoten EW; Krediet RT; le Cessie S; Wanner C; Dekker FW;
Am J Kidney Dis; 2009 Jun; 53(6):1014-23. PubMed ID: 19217702
[TBL] [Abstract][Full Text] [Related]
17. Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients.
Carrero JJ; Chmielewski M; Axelsson J; Snaedal S; Heimbürger O; Bárány P; Suliman ME; Lindholm B; Stenvinkel P; Qureshi AR
Clin Nutr; 2008 Aug; 27(4):557-64. PubMed ID: 18538898
[TBL] [Abstract][Full Text] [Related]
18. LDL-C/apoB and HDL-C/apoA-1 ratios predict incident chronic kidney disease in a large apparently healthy cohort.
Bae JC; Han JM; Kwon S; Jee JH; Yu TY; Lee MK; Kim JH
Atherosclerosis; 2016 Aug; 251():170-176. PubMed ID: 27341533
[TBL] [Abstract][Full Text] [Related]
19. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
[TBL] [Abstract][Full Text] [Related]
20. End-stage renal disease patients on renal replacement therapy in the intensive care unit: short- and long-term outcome.
Bell M; Granath F; Schön S; Löfberg E; ; Ekbom A; Martling CR
Crit Care Med; 2008 Oct; 36(10):2773-8. PubMed ID: 18766088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
